Risk of chronic kidney disease in hypertensive patients with other metabolic conditions

被引：0
|
作者：
D Weycker
G A Nichols
M O'Keeffe-Rosetti
J Edelsberg
G Vincze
Z M Khan
G Oster
机构：
[1] Policy Analysis Inc. (PAI),
[2] Kaiser Permanente,undefined
[3] Center for Health Research,undefined
[4] Novartis Pharma AG,undefined
[5] Novartis Pharmaceuticals Corporation,undefined
来源：
Journal of Human Hypertension | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 134
页数：2
相关论文
共 50 条
  • [41] Risk of malignancy in patients with chronic kidney disease
    Tendulkar, Ketki K.
    Cope, Brendan
    Dong, Jianghu
    Plumb, Troy J.
    Campbell, W. Scott
    Ganti, Apar Kishor
    PLOS ONE, 2022, 17 (08):
  • [42] Risk Scores in Patients with Chronic Kidney Disease
    Schneider, Markus P.
    Eckardt, Kai-Uwe
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (11) : 739 - 742
  • [43] Identifying patients at risk of chronic kidney disease
    Lam, Simon W.
    Eschenauer, Gregory A.
    AMERICAN FAMILY PHYSICIAN, 2007, 76 (10) : 1454 - 1454
  • [44] The risk of atherosclerosis in patients with chronic kidney disease
    Sylwia Olechnowicz-Tietz
    Anna Gluba
    Anna Paradowska
    Maciej Banach
    Jacek Rysz
    International Urology and Nephrology, 2013, 45 : 1605 - 1612
  • [45] Schizophrenia patients are at risk for other chronic health conditions
    不详
    PSYCHIATRIC ANNALS, 2007, 37 (01) : 14 - 14
  • [46] Veverimer for treatment of chronic metabolic acidosis in patients with chronic kidney disease
    Gone, Anirudh R.
    Chen, Wei
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [47] Low urine pH in hypertensive patients with chronic kidney disease (stage I-IV) and metabolic syndrome
    Bozek, T.
    Mandac, I.
    Prkacin, I.
    JOURNAL OF HYPERTENSION, 2008, 26 : S356 - S357
  • [48] Hypertensive patients with and without kidney disease: assessment of risk factors
    de Pinho, Natalia Alencar
    Burgos de Oliveira, Rita de Cassia
    Geraldo Pierin, Angela Maria
    REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2015, 49 : 99 - 106
  • [49] A comparative analysis of fructosamine with other risk factors for kidney dysfunction in diabetic patients with or without chronic kidney disease
    Neelofar, Km
    Ahmad, Jamal
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 240 - 244
  • [50] THE EFFECTS OF D VITAMIN TREATMENT ON INSULIN RESISTANCE AND OTHER METABOLIC PARAMETERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Yilmaz, Murvet
    Kudu, Aysegul
    Yucel, Fatma Sibel Kocak
    Sever, Nadiye
    Akbay, Fatih Gokhan
    Kayalar, Arzu Ozdemir
    Deger, Gunden
    Tekin, Sebnem
    Apaydin, Suheyla
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 591 - 591
12345